Research Library

Drug Policy Program director Bill Martin summarizes the scientific and fiscal evidence supporting the efficacy of syringe exchange programs and outlines a framework for public policies to deal with this aspect of drug use and abuse.

As his term progresses, President Trump will be faced with a large number of policy challenges, some of them requiring immediate science & technology expertise. In this Science Magazine article, the authors urge the president to consider the Office of Science & Technology Policy, the science advisor and the presidential S&T councils as vital resources that should be used early in the term to drive his policy agenda.

The author analyzes the major claims and implications of the Surgeon General's report "Facing Addiction in America," and proposes additional drug policy considerations for addressing substance use disorders.

Investing in child nutrition and alleviating child hunger in low-income settings are not only important from an ethics and equity perspective but also make economic sense, writes fellow Farhan Majid.

The United States has a unique opportunity to reduce the spread of disease by engaging the leaders of the G20 countries and targeting neglected diseases. Fellow Peter Hotez explains how.

This policy brief analyzes the impact of the increasing number of parents who opt their children out of school-entry vaccinations for nonmedical reasons in Texas and argues that the state should make obtaining nonmedical exemptions more rigorous in order to reduce the public health risks and costs associated with vaccine-preventable diseases.

The article analyzes the spread of neglected tropical diseases in Somolia due to severe poverty, and civil strife, and discusses the need for reforms to the country’s health systems and infrastructure.

This study examines the correlation between visceral leishmaniasis and civil unrest in East African nations.

As Zika virus infection spreads across the Latin American and Caribbean region and into the southern United States, we can expect to see thousands of additional children born with microcephaly and more newborns or older infants with signs of more subtle but significant neurologic defects and developmental delays.

Using charts, figures and graphs of this survey data originally created by former career intelligence analyst Brian C. Bennett and updated by the Drug Policy Program, this issue brief offers an overview of drug use trends in America over the last four decades. The brief is part of a larger online project chronicling the pattern of the use and abuse of individual drugs over (in most cases) more than 40 years.